🔎 Trials Near Me

Hem › Akut myeloid leukemi › Iowa › Cedar Rapids

Kliniska studier för Akut myeloid leukemi i Cedar Rapids, IA

16 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Cedar Rapids (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekryterarFas 1/2
  • University of Iowa Hospital, Iowa City · 25 mi bort
30 Days · Alla kön · Uppdaterad 16 sep. 2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

RekryterarObservationsstudie
  • University of Iowa Hospital and Clinics, Iowa City · 25 mi bort
Ålder 0 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT07154823

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

RekryterarFas 1
  • University of Iowa Health Care, Iowa City · 25 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07177079

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi bort
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • University of Iowa Stead Family Children's Hospital, Iowa City · 25 mi bort
29 Days – 21 Years · Alla kön · Uppdaterad 24 aug. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekryterarFas 3
  • University of Iowa, Iowa City · 25 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RekryterarFas 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT06001788

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RekryterarFas 3
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 17 juli 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • University of Iowa, Iowa City · 25 mi bort
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekryterarFas 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT05735184

Akut myeloid leukemi-studier i andra städer

Andra studier i Cedar Rapids

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.